Scythian Biosciences Corp. said it extended the previously announced letter of intent to buy MMJ International Investments Inc., a company pursuing medical cannabis opportunities in South America.
The companies now have until April 30 to negotiate a definitive deal, as opposed to March 31 previously.
Scythian, a Canadian medical cannabis company, added that its COO David Schrader will step down on March 31.